# OnCo record wjog (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/wjog/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "wjog" ;
  schema:name "West Japan Oncology Group"@en ;
  schema:alternateName "WJOG"@en, "West Japan Thoracic Oncology Group"@en, "WJTOG"@en ;
  schema:description "Japan's second national cooperative group, born in thoracic oncology; its WJTOG3405 trial helped establish EGFR inhibitors as first-line lung cancer therapy."@en ;
  schema:url <https://onco.cc/companies/wjog/>, <https://www.wjog.jp> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.wjog.jp> ;
  onco:tag "cooperative-group" ;
  schema:addressCountry "JP" ;
  onco:related <https://onco.cc/drugs/osimertinib/> ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:companies <https://onco.cc/companies/jcog/> ;
  onco:institutions <https://onco.cc/institutions/ncc-japan/> ;
  onco:terms <https://onco.cc/terms/oncogene-addiction/> ;
  onco:trials <https://onco.cc/trials/takahashi-pci/> ;
  onco:people <https://onco.cc/people/nobuyuki-yamamoto/> .